Lv3
388 积分 2023-10-26 加入
Immunotherapy resistance in solid tumors: mechanisms and potential solutions
4个月前
已完结
Systemic Therapy for Small Cell Lung Cancer: ASCO Guideline Rapid Recommendation Update
9个月前
已完结
Unique molecular features and clinical outcomes in young patients with non-small cell lung cancer harboring ALK fusion genes
11个月前
已完结
Safety and efficacy of first-line dacomitinib in Asian patients with EGFR mutation-positive non-small cell lung cancer: Results from a randomized, open-label, phase 3 trial (ARCHER 1050)
1年前
已完结
The Recent Advances in Molecular Diagnosis of Soft Tissue Tumors
1年前
已完结
ALK,ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
1年前
已完结
Molecular Characterization of Inflammatory Myofibroblastic Tumors With Frequent ALK and ROS1 Gene Fusions and Rare Novel RET Rearrangement
1年前
已完结
Inflammatory Myofibroblastic Tumors Harbor Multiple Potentially Actionable Kinase Fusions
1年前
已完结
Crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumours with and without anaplastic lymphoma kinase gene alterations (European Organisation for Research and Treatment of Cancer 90101 CREATE): a multicentre, single-drug, prospective, non-randomised phase 2 trial
1年前
已完结
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
1年前
已完结
Vaccine Candidate Brucella melitensis 16M ΔvjbR Is Safe in a Pregnant Sheep Model and Confers Protection
皖公网安备34019202002308
